Evolus, Inc.

By person

21 insiders · 142 transactions

5.8×

David Moatazedi holds 5.8 times base salary in stock. $4.52M of shares against $775.00K in salary for 2025.

Salary from the company's own proxy. The shares are what David Moatazedi last reported holding, valued at $9.04, the price Common Stock was last bought or sold at on the open market here, on 2 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

AEON Biopharma, Inc. entity

Former 10% Owner

—

$190.83M (7)

−$190.83M

$0.00

−100.0%

Alphaeon 1 LLC entity

10% owner

—

$40.22M (2)

−$40.22M

10,279,742

$92.91M

−30.2%

Medytox Inc. entity

Former 10% Owner

$8.06M (15)

$33.81M (10)

−$25.75M

10,640,826

$96.18M

−24.1%

Malik Vikram

Director

$26.65M (4)

$2.09M (7)

+$24.56M

1,464,810

$13.24M

+6,659%

MOATAZEDI DAVID

See Remarks

—

$16.48M (29)

−$16.48M

499,592

$4.52M

—

BLANK SIMONE

Director

$16.41M (3)

—

+$16.41M

927,471

$8.38M

—

Avelar Rui

See Remarks

—

$1.91M (15)

−$1.91M

427,423

$3.86M

+326.5%

Romine Kristine

Director

$1.54M (11)

—

+$1.54M

84,359

$762.48K

—

SILVERNAIL LAUREN P

See Remarks

—

$1.19M (6)

−$1.19M

141,571

$1.28M

—

Beaver Sandra

Chief Financial Officer

—

$437.75K (9) scheduled

−$437.75K

167,089

$1.51M

—

Parschauer Karah Herdman

Director

—

$324.20K (2)

−$324.20K

77,742

$702.67K

—

Hau Bosun

Director

$309.73K (2)

—

+$309.73K

10,040

$90.75K

—

Jafar Michael M.

See Remarks

$266.59K (1)

$20.13K (1)

+$246.46K

219,851

$1.99M

+109,826%

Stewart Brady

Director

$204.49K (1)

—

+$204.49K

134,188

$1.21M

—

GILL DAVID N

Director

$65.60K (2)

$268.67K (4)

−$203.07K

86,887

$785.33K

—

Yamagishi-Dressler Tomoko

Chief Marketing Officer

—

$192.35K (3) scheduled

−$192.35K

89,949

$813.00K

—

White Albert G III

Director

$189.00K (1)

—

+$189.00K

95,937

$867.13K

—

HAYMAN ROBERT

Director

$153.86K (3)

—

+$153.86K

65,222

$589.51K

+197,542%

Muilenburg Crystal

Chief Marketing Officer

—

$123.11K (2)

−$123.11K

134,248

$1.21M

+57.2%

FARRELL PETER C

Director

$91.05K (1)

—

+$91.05K

53,174

$480.61K

—

Mitchell Tatjana

Chief Financial Officer

—

226,092

$2.04M

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Insider

Date

Role

Action

Price

Amount

Stewart Brady

15 Aug 2025

Director

Buy

30,000

$6.82

$204.49K

White Albert G III

9 Jun 2025

Director

Buy

20,000

$9.45

$189.00K

Malik Vikram

15 Aug 2023

Director

Buy

174,967

$7.41

$1.30M

HAYMAN ROBERT

12 Sep 2022

Director

Buy indirect

1,091

$10.78

$11.76K

HAYMAN ROBERT

9 Sep 2022

Director

Buy indirect

8,909

$10.35

$92.18K

HAYMAN ROBERT

7 Sep 2022

Director

Buy

4,967

$10.05

$49.92K

FARRELL PETER C

6 Sep 2022

Director

Buy indirect

10,000

$9.10

$91.05K

BLANK SIMONE

6 Sep 2022

Director

Buy

20,000

$9.24

$184.84K

Medytox Inc.

27 Aug 2021

10% owner

Buy

51,000

$10.93

$557.57K

Medytox Inc.

26 Aug 2021

10% owner

Buy

66,000

$11.02

$727.41K

Medytox Inc.

25 Aug 2021

10% owner

Buy

44,000

$11.12

$489.39K

Medytox Inc.

24 Aug 2021

10% owner

Buy

72,219

$11.17

$807.03K

Medytox Inc.

23 Aug 2021

10% owner

Buy

69,781

$11.03

$769.78K

Medytox Inc.

20 Aug 2021

10% owner

Buy

48,000

$10.56

$506.70K

Medytox Inc.

19 Aug 2021

10% owner

Buy

55,000

$10.51

$578.11K

Medytox Inc.

18 Aug 2021

10% owner

Buy

45,000

$10.54

$474.08K

Medytox Inc.

17 Aug 2021

10% owner

Buy

70,000

$10.69

$748.06K

Medytox Inc.

16 Aug 2021

10% owner

Buy

65,000

$11.34

$737.04K

Medytox Inc.

13 Aug 2021

10% owner

Buy

49,714

$10.98

$545.72K

Medytox Inc.

13 Aug 2021

10% owner

Buy indirect

14,043

$11.11

$156.06K

Medytox Inc.

12 Aug 2021

10% owner

Buy

39,126

$10.93

$427.71K

Medytox Inc.

12 Aug 2021

10% owner

Buy indirect

23,000

$10.99

$252.77K

Medytox Inc.

11 Aug 2021

10% owner

Buy

26,160

$10.77

$281.74K

GILL DAVID N

13 Jun 2019

Director

Buy

2,000

$13.65

$27.30K

Malik Vikram

3 Jun 2019

Director

Buy indirect

1,298,701

$19.25

$25.00M

Romine Kristine

29 May 2019

Director

Buy indirect

2,090

$14.77

$30.86K

BLANK SIMONE

20 May 2019

Director

Buy indirect

628,536

$19.25

$12.10M

Romine Kristine

20 May 2019

Director

Buy

40,562

$19.25

$780.82K

Malik Vikram

17 Dec 2018

Director

Buy

7,800

$13.04

$101.69K

Romine Kristine

17 Dec 2018

Director

Buy

5,000

$12.75

$63.75K

GILL DAVID N

14 Dec 2018

Director

Buy

3,000

$12.77

$38.30K

Romine Kristine

14 Dec 2018

Director

Buy

11,000

$12.50

$137.45K

Romine Kristine

29 Nov 2018

Director

Buy

6,347

$14.00

$88.86K

BLANK SIMONE

29 Nov 2018

Director

Buy indirect

295,024

$14.00

$4.13M

Jafar Michael M.

14 Sep 2018

Chief Marketing Officer

Buy

12,800

$20.83

$266.59K

Romine Kristine

22 Aug 2018

Director

Buy

10,000

$19.83

$198.27K

Malik Vikram

14 Jun 2018

Director

Buy

8,600

$28.88

$248.35K

Romine Kristine

8 Jun 2018

Director

Buy

2,000

$28.05

$56.10K

Romine Kristine

7 Jun 2018

Director

Buy indirect

200

$33.40

$6.68K

Hau Bosun

6 Jun 2018

Director

Buy

2,898

$34.94

$101.26K

Hau Bosun

4 Jun 2018

Director

Buy

7,142

$29.19

$208.47K

Romine Kristine

1 Jun 2018

Director

Buy

4,000

$25.74

$102.95K

Romine Kristine

31 May 2018

Director

Buy indirect

1,000

$24.40

$24.40K

Romine Kristine

31 May 2018

Director

Buy

2,000

$24.40

$48.80K

Show all 142 transactions →

By person

Individual transactions

What was left out